StockWatch
·
Pharmaceutical Preparations
AGM/EGMJun 16, 2026, 08:07 AM

Azitra Stockholders Approve Share Increase to 750M, Reverse Split Authority

AI Summary

Azitra, Inc. stockholders approved several key proposals at its reconvened 2026 Annual Meeting on June 15, 2026. Major approvals include increasing the authorized common stock from 200,000,000 to 750,000,000 shares and authorizing the Board to effect one or more reverse stock splits. Additionally, four director nominees were elected, and Grassi & Co., CPAs, P.C. was ratified as the independent auditor for the fiscal year ending December 31, 2026. Stockholders also approved the issuance of over 19.99% of common stock related to two separate securities purchase agreements from November 2025 and March 2026, but did not approve an amendment to the 2023 Stock Incentive Plan to increase its share reserve.

Key Highlights

  • Stockholders approved increasing authorized common stock from 200,000,000 to 750,000,000 shares.
  • Stockholders approved authorizing the Board to effect one or more reverse stock splits.
  • Four director nominees: Francisco D. Salva, Travis Whitfill, Barbara Ryan, and John Schroer were elected.
  • Grassi & Co., CPAs, P.C. was ratified as the independent registered public accounting firm for 2026.
  • Stockholders approved issuing over 19.99% of common stock for a November 2025 securities purchase agreement.
  • Stockholders approved issuing over 19.99% of common stock for a March 2026 securities purchase agreement.
  • Stockholders did not approve an amendment to the 2023 Stock Incentive Plan to increase the authorized share reserve.